Ocular Therapeutix Stock Price on November 21, 2024
| OCUL Stock | USD 9.75 0.66 7.26% |
Below is the normalized historical share price chart for Ocular Therapeutix extending back to July 25, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Ocular Therapeutix stands at 9.75, as last reported on the 26th of November, with the highest price reaching 9.87 and the lowest price hitting 9.05 during the day.
If you're considering investing in Ocular Stock, it is important to understand the factors that can impact its price. As of now, Ocular Stock is somewhat reliable. Ocular Therapeutix maintains Sharpe Ratio (i.e., Efficiency) of 0.0218, which implies the firm had a 0.0218% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Ocular Therapeutix, which you can use to evaluate the volatility of the company. Please check Ocular Therapeutix's Risk Adjusted Performance of 0.0197, coefficient of variation of 6399.66, and Semi Deviation of 2.96 to confirm if the risk estimate we provide is consistent with the expected return of 0.0755%.
At this time, Ocular Therapeutix's Total Stockholder Equity is quite stable compared to the past year. Other Stockholder Equity is expected to rise to about 828.1 M this year, although the value of Liabilities And Stockholders Equity will most likely fall to about 126.8 M. . At this time, Ocular Therapeutix's Price Book Value Ratio is quite stable compared to the past year. Price To Book Ratio is expected to rise to 4.10 this year, although the value of Price Earnings Ratio will most likely fall to (4.63). Ocular Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 25th of July 2014 | 200 Day MA 8.1182 | 50 Day MA 9.896 | Beta 1.256 |
Ocular |
Sharpe Ratio = 0.0218
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | OCUL | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.46 actual daily | 30 70% of assets are more volatile |
Expected Return
| 0.08 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Ocular Therapeutix is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ocular Therapeutix by adding it to a well-diversified portfolio.
Price Book 4.0597 | Enterprise Value Ebitda (6.06) | Price Sales 23.3907 | Shares Float 118.9 M | Wall Street Target Price 18.2222 |
Related Headline
CytomX Therapeutics Headline on 21st of November 2024
Following the FDAs approval, Jazzs Ziihera becomes the first dual HER2-targeted bispecific antibody and chemotherapy-free treatment approved for biliary tract cancer.
Ocular Therapeutix Valuation on November 21, 2024
It is possible to determine the worth of Ocular Therapeutix on a given historical date. On November 21, 2024 Ocular was worth 8.84 at the beginning of the trading date compared to the closed value of 8.52. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Ocular Therapeutix stock. Still, in general, we apply an absolute valuation method to find Ocular Therapeutix's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Ocular Therapeutix where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Ocular Therapeutix's related companies.
| Open | High | Low | Close | Volume | |
| 8.90 | 8.99 | 8.57 | 8.78 | 797,683 | |
11/21/2024 | 8.84 | 8.88 | 8.21 | 8.52 | 1,085,438 |
| 8.59 | 8.88 | 8.41 | 8.83 | 819,876 |
| Backtest Ocular Therapeutix | | | Ocular Therapeutix History | | | Ocular Therapeutix Valuation | Previous | Next |
Ocular Therapeutix Trading Date Momentum on November 21, 2024
| On November 22 2024 Ocular Therapeutix was traded for 8.83 at the closing time. The top price for the day was 8.88 and the lowest listed price was 8.41 . The trading volume for the day was 819.9 K. The trading history from November 22, 2024 was a factor to the next trading day price upswing. The trading delta at closing time against the next closing price was 3.64% . The trading delta at closing time against the current closing price is 7.04% . |
Ocular Therapeutix Fundamentals Correlations and Trends
By evaluating Ocular Therapeutix's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Ocular Therapeutix's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Ocular financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Ocular Therapeutix Stock history
Ocular Therapeutix investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Ocular is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Ocular Therapeutix will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Ocular Therapeutix stock prices may prove useful in developing a viable investing in Ocular Therapeutix
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 85.6 M | 44.2 M | |
| Net Loss | -63.9 M | -67.1 M |
Ocular Therapeutix Quarterly Net Working Capital |
|
Ocular Therapeutix Stock Technical Analysis
Ocular Therapeutix technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Ocular Therapeutix Period Price Range
Low | November 26, 2024
| High |
0.00 | 0.00 |
Ocular Therapeutix cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Ocular Therapeutix November 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Ocular Therapeutix stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ocular Therapeutix shares will generate the highest return on investment. By undertsting and applying Ocular Therapeutix stock market strength indicators, traders can identify Ocular Therapeutix entry and exit signals to maximize returns
Ocular Therapeutix Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Ocular Therapeutix's price direction in advance. Along with the technical and fundamental analysis of Ocular Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Ocular to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0197 | |||
| Jensen Alpha | (0.18) | |||
| Total Risk Alpha | (0.49) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | 0.023 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ocular Therapeutix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. For more information on how to buy Ocular Stock please use our How to buy in Ocular Stock guide.You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocular Therapeutix. If investors know Ocular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocular Therapeutix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.29) | Revenue Per Share 0.529 | Quarterly Revenue Growth 0.083 | Return On Assets (0.22) | Return On Equity (0.73) |
The market value of Ocular Therapeutix is measured differently than its book value, which is the value of Ocular that is recorded on the company's balance sheet. Investors also form their own opinion of Ocular Therapeutix's value that differs from its market value or its book value, called intrinsic value, which is Ocular Therapeutix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocular Therapeutix's market value can be influenced by many factors that don't directly affect Ocular Therapeutix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocular Therapeutix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocular Therapeutix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocular Therapeutix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.